That's the share of GDP growth, adjusted for inflation, that AI business investment may have accounted for in the first six ...

Shares of Novo Nordisk A/S took a dive in early Monday trading after the drugmaker said oral semaglutide, which is the key ingredient in the company's Ozempic and Wegovy diabetes and weight-loss drugs ...

Stock futures pointed higher Monday to begin a holiday-shortened week, with investors increasingly confident the Federal Reserve will cut interest rates at its December meeting.

Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit ...

The domestic equity benchmarks slipped for a second straight session as profit booking and caution ahead of the US Feds December policy outlook kept sentiment muted. Traders also stayed guarded amid ...

Novo Nordisk stock dropped 9% as it said its trial of its weight-loss drug to treat Alzheimer's didn't show a delay in disease progress. Biogen, which sells an Alzheimer drug, rose 5%. Alphabet stock ...

S&P 500 is up 12.3% in 2025 and the Nasdaq is up 15.3% through Nov. 21. Both beat their long-term 10% average. A 10-year ...

Soulpower Acquisition has agreed to merge with SWB to launch Soul World Bank, a new global bank that also issues digital currency. Soulpower, a financials-focused special-purpose acquisition company, ...